The North America And Europe Stroke Diagnostics Market size is expected to reach USD 2.35 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.2% over the forecast period. Rising geriatric population in countries like U.S. and Germanyhas led to high growth of the market. Geriatric population in U.S. is anticipated to rise to around 98 million by 2060.
Unhealthy
lifestyle is another significant factor driving demand for stroke diagnostic
products. Unhealthy lifestyles and physical inactivity are attributed to rising
cases of diabetes, obesity, and other such health conditions. According to the
Centers for Disease Control and Prevention (CDC) 2017 statistics, over 36% of
U.S. population is obese. Diabetes is also one of the prevalent health
conditions in Europe. Thus, increasing incidence of such disease conditions has
propelled the market for stroke diagnostics.
Rise
in awareness among people pertaining to stroke diagnosis and treatment is also
expected to foster market growth. In 2011, the Department of Health and Human
Services in U.S. started the Million Hearts program as an initiative to avert
strokes by 2017. Building on the experience of the first five years the program
is committed to work towards prevention of 1 million strokes. The program aims
at taking steps to prevent cardiovascular diseases, such as strokes and
improving overall public health. Such awareness programs undertaken by
government are likely to boost the market growth.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/north-america-europe-stroke-diagnostics-marke
Further key findings from the study suggest:
- CT scan was
the dominant technology segment in 2016 due to its high usage rate for
stroke evaluation and is considered as a preliminary testing technique
- Carotid
ultrasound segment is anticipated to showcase lucrative CAGR during the
forecast period owing to the advantages like noninvasive technique and
cost-effectiveness
- MRI segment
held significant revenue share in 2016 owing to innovations and
advancements for improved diagnosis
- Cerebral
angiography is expected to exhibit lucrative growth during the forecast
period owing to rising adoption of minimally invasive diagnostic
techniques
- North
America held the largest market share in 2016 due to rise in unhealthy
lifestyles leading to obesity and diabetes, especially in U.S. Europe
contributed to significant market share due to increasing geriatric
population in Germany
- Some of the
key manufacturers in the North America and Europe stroke diagnostics
market are Cordis Corporation, Siemens Healthineers, GE Healthcare,
Toshiba Medical Systems Corporation, Boston Scientific Corporation,
Hitachi Medical Systems, Neusoft Medical Systems, and Philips Healthcare.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment